PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Health Economics Research Center, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, United Kingdom.\', \'Political Economy Cluster, Hertie School, 10117 Berlin, Germany.\', \'Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, United Kingdom.\', \'Department of Economics and Public Policy, Business School, Imperial College London, London SW7 2AZ, United Kingdom; m.miraldo@imperial.ac.uk.\', \'Center for Health Economics and Policy Innovation, Business School, Imperial College London, London SW7 2AZ, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • e202135911810.1073/pnas.2021359118
?:doi
?:hasPublicationType
?:journal
  • Proceedings of the National Academy of Sciences of the United States of America
is ?:pmid of
?:pmid
?:pmid
  • 33658331
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.092
?:rankingScore_hIndex
  • 675
?:title
  • Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all